Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $52 at Baird

August 19, 2026 6:37 AM

Baird analyst Joel Beatty raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $52.00 (from $28.00) while maintaining a Outperform rating.

No results found